These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38340982)

  • 41. Serotype distribution of Streptococcus pneumoniae isolated from patients with invasive pneumococcal disease in Brazil before and after ten-pneumococcal conjugate vaccine implementation.
    dos Santos SR; Passadore LF; Takagi EH; Fujii CM; Yoshioka CR; Gilio AE; Martinez MB
    Vaccine; 2013 Dec; 31(51):6150-4. PubMed ID: 23747454
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Invasive pneumococcal disease in Northern Alberta, not a Red Queen but a dark horse.
    Marrie TJ; Tyrrell GJ; Majumdar SR; Eurich DT
    Vaccine; 2018 May; 36(21):2985-2990. PubMed ID: 29685595
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Invasive pneumococcal disease burden and implications for vaccine policy in urban Bangladesh.
    Brooks WA; Breiman RF; Goswami D; Hossain A; Alam K; Saha SK; Nahar K; Nasrin D; Ahmed N; El Arifeen S; Naheed A; Sack DA; Luby S
    Am J Trop Med Hyg; 2007 Nov; 77(5):795-801. PubMed ID: 17984328
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Burden of invasive pneumococcal disease (IPD) over a 10-year period in Bogotá, Colombia.
    Severiche-Bueno DF; Severiche-Bueno DF; Bastidas A; Caceres EL; Silva E; Lozada J; Gomez S; Vargas H; Viasus D; Reyes LF
    Int J Infect Dis; 2021 Apr; 105():32-39. PubMed ID: 33582374
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluating the impact of PCV-10 on invasive pneumococcal disease in Brazil: A time-series analysis.
    Andrade AL; Minamisava R; Policena G; Cristo EB; Domingues CM; de Cunto Brandileone MC; Almeida SC; Toscano CM; Bierrenbach AL
    Hum Vaccin Immunother; 2016; 12(2):285-92. PubMed ID: 26905679
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Routine pneumococcal vaccination of children provokes new patterns of serotypes causing invasive pneumococcal disease in adults and children.
    Norton NB; Stanek RJ; Mufson MA
    Am J Med Sci; 2013 Feb; 345(2):112-20. PubMed ID: 22814362
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
    Jayasinghe S; Menzies R; Chiu C; Toms C; Blyth CC; Krause V; McIntyre P
    Clin Infect Dis; 2017 Jan; 64(2):175-183. PubMed ID: 27986682
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Invasive pneumococcal disease a decade after pneumococcal conjugate vaccine use in an American Indian population at high risk for disease.
    Weatherholtz R; Millar EV; Moulton LH; Reid R; Rudolph K; Santosham M; O'Brien KL
    Clin Infect Dis; 2010 May; 50(9):1238-46. PubMed ID: 20367225
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Invasive pneumococcal disease among the elderly in the later era of paediatric pneumococcal conjugate vaccination-A longitudinal study over 10 years based on public surveillance data in the Nordics.
    Palmborg A; Skovdal M; Molden T; Åhman H; Chen L; Banefelt J
    PLoS One; 2023; 18(6):e0287378. PubMed ID: 37363884
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Emergence of
    Camacho Moreno G; Imbachi LF; Leal AL; Moreno VM; Patiño JA; Gutiérrez IF; Beltrán S; Álvarez-Olmos MI; Mariño C; Barrero R; Espinosa F; Ramos N; Castellar LP; Sánchez N; Montañez A
    Hum Vaccin Immunother; 2020 Sep; 16(9):2300-2306. PubMed ID: 32078398
    [No Abstract]   [Full Text] [Related]  

  • 51. Invasive pneumococcal disease after implementation of 13-valent conjugate vaccine.
    Iroh Tam PY; Madoff LC; Coombes B; Pelton SI
    Pediatrics; 2014 Aug; 134(2):210-7. PubMed ID: 25002663
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidemiology of invasive pneumococcal and Haemophilus influenzae diseases in Northwestern Ontario, Canada, 2010-2015.
    Eton V; Schroeter A; Kelly L; Kirlew M; Tsang RSW; Ulanova M
    Int J Infect Dis; 2017 Dec; 65():27-33. PubMed ID: 28951105
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early Streptococcus pneumoniae serotype changes in Utah adults after the introduction of PCV13 in children.
    Kendall BA; Dascomb KK; Mehta RR; Stockmann C; Mason EO; Ampofo K; Pavia AT; Byington CL
    Vaccine; 2016 Jan; 34(4):474-478. PubMed ID: 26706276
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Temporally Associated Invasive Pneumococcal Disease and SARS-CoV-2 Infection, Alaska, USA, 2020-2021.
    Newell K; Fischer M; Massey S; Orell L; Steinberg J; Tompkins M; Castrodale L; McLaughlin J
    Emerg Infect Dis; 2023 Sep; 29(9):1765-1771. PubMed ID: 37506683
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Changes in vaccination strategies contribute to the development of invasive pneumococcal disease in allogeneic hematopoietic stem cell transplantation recipients: a retrospective study for promoting vaccination.
    Konishi T; Sekiya N; Otsuka Y; Konuma R; Wada A; Adachi H; Kishida Y; Nagata A; Yamada Y; Noguchi Y; Marumo A; Mukae J; Inamoto K; Toya T; Igarashi A; Najima Y; Kobayashi T; Sakamaki H; Ohashi K; Doki N
    Int J Hematol; 2021 Aug; 114(2):263-270. PubMed ID: 33846960
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Invasive Pneumococcal Disease and Potential Impact of Pneumococcal Conjugate Vaccines Among Adults, Including Persons Experiencing Homelessness-Alaska, 2011-2020.
    Steinberg J; Bressler SS; Orell L; Thompson GC; Kretz A; Reasonover AL; Bruden D; Bruce MG; Fischer M
    Clin Infect Dis; 2024 Jan; 78(1):172-178. PubMed ID: 37787072
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine - United States, 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Mar; 59(9):253-7. PubMed ID: 20224541
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Feb; 57(6):144-8. PubMed ID: 18272956
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups.
    Byington CL; Samore MH; Stoddard GJ; Barlow S; Daly J; Korgenski K; Firth S; Glover D; Jensen J; Mason EO; Shutt CK; Pavia AT
    Clin Infect Dis; 2005 Jul; 41(1):21-9. PubMed ID: 15937758
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults.
    Durando P; Faust SN; Fletcher M; Krizova P; Torres A; Welte T
    Clin Microbiol Infect; 2013 Oct; 19 Suppl 1():1-9. PubMed ID: 24083785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.